Biotech companies in demand as pharmaceutical companies spend billions on takeovers
With so much macroeconomic uncertainty, the recent mergers and acquisitions spree has lost momentum apart from one sector.Big pharmaceutical firms are awash with cash, yet patent cliffs (expiration of patent protection) present...
15 June 2023
